vs
协鑫环球控股有限公司(GCL)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是协鑫环球控股有限公司的2.0倍($194.3M vs $98.7M),REPLIGEN CORP净利率更高(4.3% vs -5.2%,领先9.5%)
协鑫环球控股有限公司是全球领先的清洁能源企业,主营光伏产品、储能系统与低碳能源解决方案的研发、生产及运营,业务覆盖亚、欧、北美等地区,服务于集中式电站、工商业及户用分布式能源客户。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
GCL vs RGEN — 直观对比
营收规模更大
RGEN
是对方的2.0倍
$98.7M
净利率更高
RGEN
高出9.5%
-5.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $98.7M | $194.3M |
| 净利润 | $-5.1M | $8.3M |
| 毛利率 | 11.0% | 55.7% |
| 营业利润率 | -6.7% | 8.2% |
| 净利率 | -5.2% | 4.3% |
| 营收同比 | — | 14.8% |
| 净利润同比 | — | 42.9% |
| 每股收益(稀释后) | $-0.04 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GCL
RGEN
| Q1 26 | — | $194.3M | ||
| Q4 25 | — | $197.9M | ||
| Q3 25 | $98.7M | $188.8M | ||
| Q2 25 | $142.1M | $182.4M | ||
| Q1 25 | — | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | $36.1M | $154.9M | ||
| Q2 24 | — | $154.1M |
净利润
GCL
RGEN
| Q1 26 | — | $8.3M | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-5.1M | $14.9M | ||
| Q2 25 | $5.6M | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-1.9M | $-654.0K | ||
| Q2 24 | — | $3.3M |
毛利率
GCL
RGEN
| Q1 26 | — | 55.7% | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | 11.0% | 53.2% | ||
| Q2 25 | 15.0% | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 16.2% | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率
GCL
RGEN
| Q1 26 | — | 8.2% | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | -6.7% | 8.9% | ||
| Q2 25 | 2.3% | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | -5.6% | -5.1% | ||
| Q2 24 | — | 1.0% |
净利率
GCL
RGEN
| Q1 26 | — | 4.3% | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | -5.2% | 7.9% | ||
| Q2 25 | 3.9% | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -5.2% | -0.4% | ||
| Q2 24 | — | 2.2% |
每股收益(稀释后)
GCL
RGEN
| Q1 26 | — | $0.15 | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.04 | $0.26 | ||
| Q2 25 | $0.05 | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $16.6M | $582.6M |
| 总债务越低越好 | $52.0M | — |
| 股东权益账面价值 | $33.1M | — |
| 总资产 | $159.9M | $2.9B |
| 负债/权益比越低杠杆越低 | 1.57× | — |
8季度趋势,按日历期对齐
现金及短期投资
GCL
RGEN
| Q1 26 | — | $582.6M | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | $16.6M | $748.7M | ||
| Q2 25 | $18.2M | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $2.7M | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | $52.0M | $537.9M | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $2.1B | ||
| Q3 25 | $33.1M | $2.1B | ||
| Q2 25 | $35.9M | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $15.9M | $2.0B | ||
| Q2 24 | — | $2.0B |
总资产
GCL
RGEN
| Q1 26 | — | $2.9B | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | $159.9M | $2.9B | ||
| Q2 25 | $101.6M | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $49.6M | $2.8B | ||
| Q2 24 | — | $2.9B |
负债/权益比
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | 1.57× | 0.26× | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-5.2M | — |
| 自由现金流率自由现金流/营收 | -5.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $25.7M | ||
| Q3 25 | $-4.8M | $48.1M | ||
| Q2 25 | $-10.3M | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | $6.1M | $49.3M | ||
| Q2 24 | — | $42.2M |
自由现金流
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | $-5.2M | $43.4M | ||
| Q2 25 | $-10.5M | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | -5.3% | 23.0% | ||
| Q2 25 | -7.4% | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | 0.4% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率
GCL
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | -1.84× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GCL
暂无分部数据
RGEN
| Product | $194.2M | 100% |
| Royalty and other revenue | $44.0K | 0% |